当前位置: 首页 >> 检索结果
323. Prevalence, distribution and associations of the scleroderma capillaroscopic patterns: new insights from the Italian SPRING-SIR registry.
作者: Rossella De Angelis.;Clodoveo Ferri.;Edoardo Cipolletta.;Valeria Riccieri.;Marco Di Battista.;Gianluigi Bajocchi.;Silvia Bellando-Randone.;Cosimo Bruni.;Martina Orlandi.;Giovanni Zanframundo.;Roberta Foti.;Giovanna Cuomo.;Alarico Ariani.;Edoardo Rosato.;Gemma Lepri.;Francesco Girelli.;Elisabetta Zanatta.;Silvia Laura Bosello.;Ilaria Cavazzana.;Francesca Ingegnoli.;Maria De Santis.;Fabio Cacciapaglia.;Giuseppe Murdaca.;Giuseppina Abignano.;Giorgio Pettiti.;Alessandra Della Rossa.;Maurizio Caminiti.;Anna Maria Iuliano.;Giovanni Ciano.;Lorenzo Beretta.;Gianluca Bagnato.;Ennio Lubrano.;Ilenia De Andres.;Luca Idolazzi.;Marta Saracco.;Cecilia Agnes.;Corrado Campochiaro.;Marco Fornaro.;Federica Lumetti.;Amelia Spinella.;Emanuele Cocchiara.;Giacomo De Luca.;Veronica Codullo.;Elisa Visalli.;Carlo Iandoli.;Antonietta Gigante.;Greta Pellegrino.;Erika Pigatto.;Maria Grazia Lazzaroni.;Enrico De Lorenzis.;Francesca Motta.;Antonio Tonutti.;Gianna Mennillo.;Giuseppa Pagano-Mariano.;Federica Furini.;Licia Vultaggio.;Simone Parisi.;Clara Lisa Peroni.;Gerolamo Bianchi.;Enrico Fusaro.;Gian Domenico Sebastiani.;Marcello Govoni.;Salvatore D'Angelo.;Franco Cozzi.;Franco Franceschini.;Serena Guiducci.;Dilia Giuggioli.;Lorenzo Dagna.;Andrea Doria.;Carlo Salvarani.;Florenzo Iannone.;Marco Matucci-Cerinic.; .
来源: Rheumatology (Oxford). 2026年65卷1期
To assess the relationship between disease duration and the prevalence/distribution of nailfold videocapillaroscopy (NVC) patterns, named according to the current classification as 'early', 'active' and 'late', in a large cohort of systemic sclerosis (SSc) patients.
325. Diffuse alveolar haemorrhage in antiphospholipid syndrome: a French series of 26 patients.
作者: Vincent Grobost.;Mélanie Ramos.;Cécile Yelnik.;Marie De Antonio.;Nathalie Morel.;Jean-François Viallard.;Eric Hachulla.;Marc André.;Anne-Marie Milesi Lecat.;Sébastien Trouillier.;Maxime Samson.;Christian Lavigne.;Aurelien Lebreton.;Marc Lambert.;Marc Ruivard.;Nathalie Costedoat-Chalumeau.
来源: Rheumatology (Oxford). 2026年65卷3期
Diffuse alveolar haemorrhage (DAH) is a rare and poorly understood manifestation of antiphospholipid (AP) syndrome (APS). This study describes the clinical presentation, treatment and prognosis of DAH in APS with or without catastrophic APS (CAPS).
326. Comment on: How early is early for JIA? Insights from the infantile-onset juvenile idiopathic arthritis patients of the PERA research group cohort: reply.
作者: Kubra Ozturk.;Tuncay Aydin.;Gulcan Ozomay Baykal.;Esra Baglan.;Hulya Kose.;Hakan Kisaoglu.;Deniz Gezgin Yildirim.;Fatma Gul Demirkan.;Gulcin Otar Yener.;Mustafa Çakan.;Belde Kasap Demir.;Hatice Adiguzel Dundar.;Gulsah Kilbas.;Hafize Emine Sonmez.;Serkan Turkucar.;Balahan Bora.;Selcuk Yuksel.;Nuray Aktay Ayaz.;Sevcan Bakkaloglu.;Mukaddes Kalyoncu.;Sara Sebnem Kilic.;Semanur Ozdel.;Betul Sozeri.;Erbil Unsal.
来源: Rheumatology (Oxford). 2026年65卷2期 327. Systemic inflammation in gout and the impact of treat-to-target urate-lowering therapy.
作者: Austin M Wheeler.;Tanner J Ourada.;Spencer Q Jones.;Michael J Duryee.;Bryant R England.;Richard J Reynolds.;James R O'Dell.;Jeff Newcomb.;Michael H Pillinger.;Robert Terkeltaub.;Ryan Ferguson.;Mary Brophy.;Brian LaMoreaux.;Tony R Merriman.;Ted R Mikuls.
来源: Rheumatology (Oxford). 2025年
We tested the hypotheses that individuals with gout would have distinct circulating inflammatory biomarker patterns compared with non-gout controls and that these differences would be attenuated with highly-effective urate-lowering therapy (ULT).
328. Loss of antiphospholipid antibody positivity decreases the risk of recurrent thrombosis in thrombotic antiphospholipid syndrome.
作者: Pedro Gaspar.;Ana Rita Cruz-Machado.;Ana Mafalda Abrantes.;Filipa Costa.;Inês Parreira.;Ana Rita Lopes.;Ryan Costa-Silva.;Ana Teodósio Chícharo.;Joana Rosa Martins.;João Pedro Marques.;Diogo Santos.;Vasco C Romão.;Luis Graca.;João E Fonseca.
来源: Rheumatology (Oxford). 2026年65卷1期
To establish the predictive value of antiphospholipid antibody (aPL) negativization on recurrent thrombosis in thrombotic antiphospholipid syndrome (APS).
331. Prevalence, clinical associations and outcomes of pericarditis in systemic lupus erythematosus: insights from the University of Toronto Lupus Clinic.
作者: Pankti Mehta.;Fadi Kharouf.;Virginia Carrizo-Abarza.;Qixuan Li.;Shadi Akhtari.;Paula Harvey.;Oluwatosin Osuntokun.;Laura P Whittall Garcia.;Dafna D Gladman.;Zahi Touma.
来源: Rheumatology (Oxford). 2026年65卷2期
Pericarditis is an important clinical feature in the classification criteria and disease activity indices in SLE. We aimed to study the prevalence, associations and outcomes of pericarditis in SLE.
332. Sirolimus to treat chronic uveitis in PTEN hamartoma tumor syndrome: experience of a target therapy customized on specific disease pathway.
作者: Laura Gatti.;Cinzia de Libero.;Edoardo Marrani.;Ilaria Pagnini.;Maria Vincenza Mastrolia.;Gabriele Simonini.;Ilaria Maccora.
来源: Rheumatology (Oxford). 2026年65卷1期 333. Predictors and long-term impact of sustained complete renal response in lupus nephritis patients over a median 10-year follow-up.
作者: Ioannis E Michelakis.;Eleni Kapsia.;John N Boletis.;Smaragdi Marinaki.;Petros P Sfikakis.;Maria G Tektonidou.
来源: Rheumatology (Oxford). 2026年65卷3期
Complete renal response (CRR) is a primary goal in lupus nephritis (LN) management. We examined the prevalence and predictors of sustained CRR (sCRR) and long-term outcomes.
335. Glucocorticoids rarely required in granulocyte colony-stimulating factor-associated large-vessel vasculitis: Japanese cancer centre cohort.
作者: Yuka Morita.;Koichi Takeda.;Hiroki Osumi.;Yosuke Aoyama.;Naoki Fukuda.;Keitaro Shimozaki.;Shohei Udagawa.;Shota Fukuoka.;Mariko Ogura.;Takeru Wakatsuki.;Akira Ooki.;Keisho Chin.;Eiji Shinozaki.;Toshimi Takano.;Taro Shiga.;Kensei Yamaguchi.
来源: Rheumatology (Oxford). 2026年65卷2期
To evaluate the efficacy of glucocorticoid-sparing management in patients with G-CSF-associated large-vessel vasculitis (LVV).
337. International development and validation of a multilingual bank of items for the self-assessment of essential knowledge by systemic lupus erythematosus patients: the SLE Knowledge Assessment score (SLAKE).
作者: Antonin Satrin.;Matteo Piga.;Mariele Gatto.;Yurilis Fuentes-Silva.;José A Gomez Puerta.;Ivan Padjen.;Guillermo Pons-Estel.;Manuel F Ugarte-Gil.;Carlos Enrique Toro-GutiÉrrez.;Alexandra Legge.;Ali Duarte-Garcia.;François Chasset.;Ioannis Parodis.;Katia Baumgaertner.;Laurent Chiche.;Odirlei A Monticielo.;Omondi Oyoo.;Raquel Faria.;Shinji Izuka.;Sofia Silva-Ribeiro.;Galymzhan Togizbayev.;Daniela Opris-Belinski.;Lina El Kibbi.;Amita Aggarwal.;Mithu Maheswaranathan.;Tai-Ju Lee.;Sheilla Achieng.;Anastasiia Shumilova.;Ricard Cervera.;Gamal Chehab.;Faisal Parlindungan.;Sander Van Leuven.;Karoline Lerang.;Jeanette Andersen.;Francesca Marchiori.;Zoe Karakikla-Mitsakou.;Christelle Sordet.;Laurent Arnaud.; .
来源: Rheumatology (Oxford). 2026年65卷2期
Patient education is increasingly acknowledged as an important aspect of the management of systemic lupus erythematosus (SLE). The aim of the study was to develop the SLE Knowledge Assessment score (SLAKE), a digital multilingual self-assessment tool designed to quantify essential SLE knowledge.
338. Early antiproteinuric effect of voclosporin in patients with LN in a real-life setting: preliminary results from the VoRLiSS (Voclosporin in Real Life Setting Study) experience.
作者: Luca Iaccarino.;Aurora Di Gregorio.;Marta Calatroni.;Marco Allinovi.;Alessandra Bortoluzzi.;Giorgio Buscetta.;Rossella De Angelis.;Ginevra De Marchi.;Giacomo Emmi.;Pasquale Esposito.;Paride Fenaroli.;Cinzia Ferio.;Franco Franceschini.;Micaela Fredi.;Francesco Gozza.;Giuliana Marongiu.;Giovanni Orsolini.;Giulia Pazzola.;Daniela Picciotto.;Luca Quartuccio.;Francesca Ruzzon.;Domenico Santoro.;Ettore Silvagni.;Paola Tomietto.;Filippo Vesentini.;Margherita Zen.;Andrea Doria.;Gabriella Moroni.
来源: Rheumatology (Oxford). 2026年65卷1期
To assess efficacy of voclosporin (VCL) from a retrospective, observational, clinical-practice-based, nationwide multicentre study of patients with LN.
339. Immunosuppressant use and adverse pregnancy outcomes in women with systemic lupus erythematosus: a retrospective cohort study in Korea.
作者: Yu-Seon Jung.;Yeo-Jin Song.;Eun Jin Jang.;Soo-Kyung Cho.;Yoon-Kyoung Sung.;Sun-Young Jung.
来源: Rheumatology (Oxford). 2026年65卷2期
This study aimed to estimate the incidence of adverse pregnancy outcomes (APO) in patients with systemic lupus erythematosus (SLE) and to evaluate the risks associated with immunosuppressant use-including hydroxychloroquine and teratogenic agents such as mycophenolate mofetil, methotrexate and cyclophosphamide-across specific APO categories.
340. Comment on: risk of urinary tract infections associated with SGLT2 inhibitor use in patients with rheumatoid arthritis: a target trial emulation study: reply.
作者: Naofumi Dobashi.;Ken-Ei Sada.;Masataka Kudo.;Shigemi Morishita.;Sho Sasaki.;Narufumi Suganuma.
来源: Rheumatology (Oxford). 2026年65卷2期 |